The value of circulation tumor DNA in predicting postoperative recurrence of colorectal cancer: a meta-analysis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology
Link
https://link.springer.com/content/pdf/10.1007/s00384-020-03667-y.pdf
Reference40 articles.
1. Diehl F, Schmidt K, Choti MA, Romans K, Goodman S, Li M, Thornton K, Agrawal N, Sokoll L, Szabo SA, Kinzler KW, Vogelstein B, Diaz Jr LA (2008) Circulating mutant DNA to assess tumor dynamics. Nat Med 14(9):985–990. https://doi.org/10.1038/nm.1789
2. Siegel RL, Sahar L, Portier KM, Ward EM, Jemal A (2015) Cancer death rates in US congressional districts. CA Cancer J Clin 65(5):339–344. https://doi.org/10.3322/caac.21292
3. Venook AP, Niedzwiecki D, Lenz H-J, Innocenti F, Fruth B, Meyerhardt JA, Schrag D, Greene C, O'Neil BH, Atkins JN, Berry S, Polite BN, O'Reilly EM, Goldberg RM, Hochster HS, Schilsky RL, Bertagnolli MM, el-Khoueiry AB, Watson P, Benson AB III, Mulkerin DL, Mayer RJ, Blanke C (2017) Effffect of fifirst-line chemotherapy combined with cetuximab or bevacizumab on overall survival in patients with KRAS wild-type advanced or metastatic colorectal cancer: a randomized clinical trial. JAMA 317(23):2392–2401. https://doi.org/10.1001/jama.2017.7105
4. Loupakis F, Cremolini C, Masi G, Lonardi S, Zagonel V, Salvatore L, Cortesi E, Tomasello G, Ronzoni M, Spadi R, Zaniboni A, Tonini G, Buonadonna A, Amoroso D, Chiara S, Carlomagno C, Boni C, Allegrini G, Boni L, Falcone A (2014) Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer. N Engl J Med 371:1609–1618. https://doi.org/10.1056/NEJMoa1403108
5. Jeffery M, Hickey HE, Hider PN, See AM (2016) Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Databas Syst Rev 2016(11):CD002200. https://doi.org/10.1002/14651858.CD002200.pub3
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Circulating tumor DNA (ctDNA) as prognostic markers of relapsed breast cancer: a systematic review and meta-analysis;Journal of the National Cancer Center;2024-01
2. Utility of circulating tumor DNA in patients undergoing hepatectomy for colorectal liver metastases;Hepatobiliary Surgery and Nutrition;2023-10
3. Association of ctDNA detection and recurrence assessment in patients with neoadjuvant treatment;Cancer Medicine;2023-09-25
4. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Rectal Cancer 2023 Supplement;Diseases of the Colon & Rectum;2023-08-20
5. Circulating Tumor DNA as a Minimal Residual Disease Assessment and Recurrence Risk in Patients Undergoing Curative-Intent Resection with or without Adjuvant Chemotherapy in Colorectal Cancer: A Systematic Review and Meta-Analysis;International Journal of Molecular Sciences;2023-06-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3